Website Logo

Press

Keep up-to-date with relevant news, important announcements and key market insights.

READ MORE
FEATURED

Together Caring for Rare Disease

Resource

About Bionical Emas

Bionical Emas is the only Contract Research Organization that combines Clinical Development, Clinical Trial Supply (CTS) and Early Access Programs (EAP) to deliver a unique, seamless approach to bring life-changing medicines to patients around the world.

Learn more
READ MORE

Together Caring for Rare Disease

Resource

READ MORE

The Guardian - Inviting patients as equal partners in the drug development process

News

READ MORE

Tom Watson appointed Chief Executive Officer

Press Release

READ MORE

Carl Hvass appointed Chief Financial Officer

Press Release

READ MORE

Medics 4 Rare Diseases - The Rare Disease Podcast 4 Medics

Resource

READ MORE

Auxora vs. placebo for the treatment of patients with severe COVID-19 pneumonia

Resource

READ MORE

Amylyx Pharmaceuticals Announces Launch of U.S. Expanded Access Program for AMX0035

Press Release

READ MORE

Webinar: Operationalize Expanded Access Programs

Resource

READ MORE

Webinar: The International Rare Disease Showcase

Resource

READ MORE

Bionical Emas to establish European storage, distribution and labelling facility in Co. Westmeath

Press Release

READ MORE

Janssen Guide to Expanded Access

Resource

READ MORE

What is an Early Access Program?

Resource

1 / 3

How else can we help?

Discover more about the services and capabilities Bionical Emas has to offer

READ MORE

Clinical Development

READ MORE

Clinical Trial Supply

READ MORE

Early Access Programs